Isotretinoin‐induced hair disorders in the era of <scp>COVID</scp> ‐19 and related vaccines: A case series-Reference-Cited by-同舟云学术

Isotretinoin‐induced hair disorders in the era of COVID ‐19 and related vaccines: A case series

Published:2022-08-08 Issue:9 Volume:21 Page:3651-3654
ISSN:1473-2130
Container-title:Journal of Cosmetic Dermatology
language:en
Short-container-title:J of Cosmetic Dermatology

Author:

Abdelmaksoud Ayman¹²^ORCID,Temiz Selami Aykut³⁴^ORCID,Dursun Recep⁴,Wollina Uwe⁵^ORCID,Rudnicka Lidia⁶,Işık Begüm⁴,Lotti Torello⁷⁸,Vestita Michelangelo⁹¹⁰

Affiliation:

1. Mansoura Dermatology, Venerology and Leprology Hospital Mansoura Egypt

2. Department of Dermatology University of Studies Guglielmo Marconi Rome Italy

3. Department of Dermatology Konya Ereğli State Hospital Konya Turkey

4. Department of Dermatology Necmettin Erbakan University Meram Medical Faculty Konya Turkey

5. Department of Dermatology and Allergology Städtisches Klinikum Dresden, Academic Teaching Hospital Dresden Germany

6. Department of Dermatology Medical University of Warsaw Warsaw Poland

7. University of Rome G. Marconi Rome Italy

8. Department of Dermatology and Communicable Diseases First Medical State Moscow University I. M. Sechenev Moscow Russia

9. Unit of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation University of Bari Bari Italy

10. Department of Dermatology Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocd.15214

Reference14 articles.

1. The use of isotretinoin for acne – an update on optimal dosing, surveillance, and adverse effects

2. Low‐dose oral isotretinoin for the treatment of adult patients with mild‐to‐moderate acne vulgaris: Systematic review and meta‐analysis

3. Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review

4. Acne Scars: How Do We Grade Them?

5. FDA Reports of Alopecia as an Adverse Event to Isotretinoin

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the therapeutic effects of isotretinoin on patients with coronavirus disease 2019 (COVID-19): A controlled open-label clinical trial;Heliyon;2024-03

2. Characteristics of hair loss in COVID-19 patients in Thailand;Medicine;2023-12-08

3. Interesting cases of everyday practice with isotretinoin use: ten years later;Klinicheskaya dermatologiya i venerologiya;2023